Skip to main content
#MLK - “The ultimate measure of a man is not where he stands in moments of comfort and convenience, but where he stands at times of challenge and co

Dr. John Cush RheumNow

6 years 8 months ago
#MLK - “The ultimate measure of a man is not where he stands in moments of comfort and convenience, but where he stands at times of challenge and controversy.” - Martin Luther King, Jr.
QD Clinic - Lessons from the clinic. Today’s clinic topic: Dealing with Non-Adherence in the Clinic.
#MLK - “If you can’t fly then run, if you can’t run then walk, if you can’t walk then crawl, but whatever you do you have to keep moving forwa

Dr. John Cush RheumNow

6 years 8 months ago
#MLK - “If you can’t fly then run, if you can’t run then walk, if you can’t walk then crawl, but whatever you do you have to keep moving forward.” - Martin Luther King Jr.
A controlled clinical trial has shown that giving the IL-6 receptor antibody, tocilizumab (TCZ), to  patients with Takayasu arteritis (TAK) results in clinical efficacy and has a steroid sparing efffect.
#MLK "Everybody can be great … because anybody can serve. You don’t have to have a college degree to serve. You don’t have to make your subject

Dr. John Cush RheumNow

6 years 8 months ago
#MLK "Everybody can be great … because anybody can serve. You don’t have to have a college degree to serve. You don’t have to make your subject and verb agree to serve. You only need a heart full of grace. A soul generated by love.” - Martin Luther King
RT @drdavidliew: The future is bedside-to-bench:
"Systemic comparison (of immunotherapy irAEs) with canonical forms of (inflamm arthritis).…

David Liew drdavidliew

6 years 9 months ago
The future is bedside-to-bench: "Systemic comparison (of immunotherapy irAEs) with canonical forms of (inflamm arthritis)... may shed novel insights into the development of IA more broadly and identify common mechanisms and targets for therapy" @cappelliMD https://t.co/zYZyUFx8KU
Thanks to Irwin and Rheuma Republic for this generous bio and profile of yours truly. RheumNow gives me a daily chance to spread the wealth or to get

Dr. John Cush RheumNow

6 years 9 months ago
Thanks to Irwin and Rheuma Republic for this generous bio and profile of yours truly. RheumNow gives me a daily chance to spread the wealth or to get it right! https://t.co/gvQf5sUF3m
RT @synovialjoints: Attending the annual ASAS meeting in Houston and hearing about the development of new platforms to disseminate informat…

Dr. Antoni Chan synovialjoints

6 years 9 months ago
Attending the annual ASAS meeting in Houston and hearing about the development of new platforms to disseminate information on #spondyloarthritis #axialspondyloarthritis https://t.co/uqDxbkHX7N
23% of RA patients have moderate-to-severe Obstructive Sleep Apnea (AHI ≥ 15) - study of RA patients 199 patients underwent PSG, OSA is more common

Dr. John Cush RheumNow

6 years 9 months ago
23% of RA patients have moderate-to-severe Obstructive Sleep Apnea (AHI ≥ 15) - study of RA patients 199 patients underwent PSG, OSA is more common in RA than in the general population, but there is no relationship with disease activity. https://t.co/noojvYmtMk
Analysis of worldwide data on Abatacept shows that compared with other bDMARDs, ABA was not associated with an increased overall cancer risk [ROR 0.9

Dr. John Cush RheumNow

6 years 9 months ago
Analysis of worldwide data on Abatacept shows that compared with other bDMARDs, ABA was not associated with an increased overall cancer risk [ROR 0.98 (95% CI 0.91, 1.05)], but may be increased for risk of melanoma [1.58 (95% CI 1.17, 2.08)] https://t.co/3EI52M5kIR
×